Reassessment of clostridium difficile susceptibility to metronidazole and vancomycin

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 6, 2002, Pages 1647-1650

  Pelaez T ^a   Alcala L ^a   Alonso, R ^a   Rodriguez Creixems M ^a   Garcia Lechuz J M ^a   Bouza, E ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METRONIDAZOLE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DIARRHEA; HOSPITAL INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; NONHUMAN; PRIORITY JOURNAL;

ADULT; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; DRUG RESISTANCE, MICROBIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HIV INFECTIONS; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; TIME FACTORS; VANCOMYCIN;

EID: 0036095979     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.6.1647-1650.2002     Document Type: Article

References (51)

1. Update on Clostridium difficile infection
2. Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches
3. Molecular analysis of relapse vs re-infection in HIV-positive patients suffering from recurrent Clostridium difficile associated diarrhoea
4. Rapid detection of toxigenic Clostridium difficile from stool samples by a nested PCR of toxin B gene
5. High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients
6. Clostridium difficile-associated diarrhea in HIV-infected patients: Epidemiology and risk factors
7. Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea
8. Clostridium difficile-associated colitis after neomycin treated with metronidazole
9. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile
10. Infección causada por Clostridium difficile. Situación en los 90
11. Diarrea asociada a Clostridium difficile: Experiencia durante un año en un Hospital General
12. 'Second-look' cytotoxicity: An evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD
13. Microbiology, epidemiology and diagnosis of Clostridium difficile infection
14. Metronidazole: An alternate therapy for antibiotic-associated colitis
15. Update on diagnosis of Clostridium difficile-associated diarrhea
16. Antibiotic resistance of Clostridium difficile isolates
17. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis
18. Treatment of antibiotic-associated colitis with vancomycin
19. Treatment of Clostridium difficile-associated diarrhea and colitis
20. In vitro susceptibility of Clostridium difficile isolates to 12 antimicrobial agents
21. Metronidazole or vancomycin for Clostridium difficile associated diarrhoea
22. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission
23. Comparative activity of metronidazole and tinidazole against Clostridium difficile and Peptostreptococcus anaerobius
24. Community-acquired Clostridium difficile infection
25. Clostridium difficile-associated diarrhea: Epidemiology, risk factors, and infection control
26. Clostridium difficile-associated diarrhea in patients with HIV positivity and AIDS: A prospective controlled study
27. Environmental control to reduce transmission of Clostridium difficile
28. Review of Clostridium difficile-associated diseases
29. Recurrent Clostridium difficile disease: Epidemiology and clinical characteristics
30. Clostridium difficile-associated diarrhea in a VA medical center: Clustering of cases, association with antibiotic usage, and impact on HIV-infected patients
31. Oral metronidazole in Clostridium difficile colitis
32. Clostridium difficile-associated diarrhea: A review
33. Antimicrobial susceptibility of Clostridium difficile from different sources
34. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983
35. In vitro susceptibility of anaerobic bacteria to nitroimidazoles
36. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use
37. Clostridium difficile and vancomycin-resistant enterococcus: The new nosocomial alliance
38. Vancomycin-resistant enterococci in stool specimens submitted for Clostridium difficile cytotoxin assay
39. Antibiotic-induced colitis: Implication of a toxin neutralised by Clostridium sordellii antitoxin
40. Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia
41. Colitis associated with metronidazole therapy
42. "Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy
43. Clostridium difficile as a nosocomial pathogen
44. Comparison of arbitrarily primed PCR with restriction endonuclease and immunoblot analyses for typing Clostridium difficile isolates
45. Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis
46. Colitis caused by Clostridium difficile: A review
47. Susceptibility testing of Clostridium difficile against metronidazole and vancomycin by disk diffusion and Etest
48. Antibacterial activity of teicoplanin against Clostridium difficile
49. Clostridium difficile infections in HIV-positive patients